New Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
NCT07635953
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
296
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus
Interventions
DRUG:
Group A (triple combination intensive therapy group)
DRUG:
Group B (standard therapy group)
Sponsor
Sun Yat-sen University